Status:
TERMINATED
Investigation of Neuroserpin as an Autism Candidate Gene
Lead Sponsor:
State University of New York - Upstate Medical University
Conditions:
Autism
Eligibility:
All Genders
1+ years
Brief Summary
Previously it has been shown that Familial Encephalopathy with neuroserpin inclusion bodies (FENIB) patients develop abnormalities that partially overlap with Autism Spectrum disorders (ASD), confound...
Detailed Description
It is proposed to perform a pilot study to ask whether genetic variation at SERPINI1 is contributing to idiopathic autism. To maximize the chance of finding such variants, the perseveration and langua...
Eligibility Criteria
Inclusion
- Autistic patient, or first degree relative of autistic patient
Exclusion
- Less than one year of age.
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2012
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT00917683
Start Date
June 1 2009
End Date
April 1 2012
Last Update
April 19 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SUNY Upstate Medical University
Syracuse, New York, United States, 13210